People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

Study reveals a higher frequency of polyp diagnoses in relatives increases the risk of colorectal cancer, especially ...

Barry Stein had ignored symptoms that started appearing in 1995. Now he's committed to helping people recognize the signs of ...

While there’s no way to pin down the specific cause of polyp formation, there are a few things that can increase your risk of developing polyps and colorectal cancer: Because most colon adenomas are ...

Medical device firm Creo Medical Group said on Thursday that the Aneurin Bevan University Health Board had initiated a ...

Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...

LONDON - Aneurin Bevan University Health Board (ABUHB) in Wales has initiated a six-month pilot program for a new medical device known as Speedboat®, developed by Creo Medical (TASE:PMCN) Group plc ...

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...

Colorectal cancer is becoming a significant public health issue in India, especially among individuals under 50 years old.

OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...

Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal ...